Results 121 to 130 of about 23,588 (182)

Health-related quality of life and mental health in autoimmune thrombotic thrombocytopenic purpura patients in the caplacizumab era. [PDF]

open access: yesRes Pract Thromb Haemost
Weisinger J   +19 more
europepmc   +1 more source

Novel cryptic ADAMTS13 epitopes uncover a distinct open ADAMTS13 conformation in immune-mediated TTP. [PDF]

open access: yesHaematologica
Bonnez Q   +13 more
europepmc   +1 more source

Immune Thrombocytopenic Purpura

New England Journal of Medicine, 2002
Immune thrombocytopenic purpura, which may lead to bleeding, is typically caused by antibodies directed against the platelet glycoprotein IIb/IIIa complex. Since the management of the disorder is different for children and adults, the authors of this up-to-date review provide separate sections on the two age groups.
Douglas B, Cines, Victor S, Blanchette
exaly   +6 more sources

THROMBOHEMOLYTIC THROMBOCYTOPENIC PURPURA

Archives of Internal Medicine, 1954
THE DISEASE thrombotic thrombocytopenic purpura refers to a condition characterized by an unusual triad: hemolytic anemia, thrombocytopenic purpura, and multiple hyaline thrombi throughout the small vessels of the body. The occurrence of thrombi in cranial blood vessels gives rise to the characteristic cerebral symptoms.
E, ADELSON   +2 more
openaire   +2 more sources

Immune Thrombocytopenic Purpura

Hematology/Oncology Clinics of North America, 2007
Immune thrombocytopenic purpura (ITP) is an autoantibody-mediated thrombocytopenic disorder in which accelerated destruction of platelets occurs; platelet production may also be impaired by these antibodies. ITP is characterized by mucocutaneous bleeding. Rarely, more severe hemorrhages, such as intracranial hemorrhage, may occur. Traditional therapies,
Bethan, Psaila, James B, Bussel
openaire   +2 more sources

Home - About - Disclaimer - Privacy